Spontaneous Subcapsular Hematoma from Rivaroxaban
Journal: Archives of Hematology Case Reports and Reviews (Vol.3, No. 1)Publication Date: 2018-12-21
Authors : Swetha Chenna Amy R Hurst Jason B Douglas Venu Madhav Chippa Matthew R Fulton; Amr Moussa;
Page : 004-006
Keywords : ;
Abstract
Rivaroxaban was approved for stroke prevention for non-valvular atrial fibrillation in 2011, with added advantage of decreased risk of bleeding in comparison to coumadin, made it a good alternative for coumadin. We report a case of severe subcapsular and intrarenal hematoma associated with Rivaroxaban in an elderly male with chronic kidney disease. He presented with severe left sided flank pain, shock and acute on chronic renal failure, he was successfully resuscitated with supportive care. We aim to alert primary care physicians, hospitalists, Emergency room physicians and cardiologists regarding the likelihood of encountering similar cases as the indications of direct acting oral anticoagulants are increasing and gaining more popularity in physicians and patients as well.
Other Latest Articles
- Secondary Breast Lymphoma: A Case Report
- The Epidemiology and Prognosis of Cerebral Venous Sinus Thrombosis in a Third Level Hospital
- Multiple Myeloma with scleroderma and second malignancy: A case report
- PECULIARITIES OF FIRST-YEAR STUDENTS’ VALUE ORIENTATIONS
- Are We Performing the Right Long Term Thromboprophylaxis of Port-A-Cath? Report of a Case of Upper Limb DVT with PE and Port-A-Cath Migration
Last modified: 2019-01-09 21:41:43